These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 2710587)
1. How experimental drugs are tested in humans. Flieger K Pediatr Infect Dis J; 1989 Mar; 8(3):160-2. PubMed ID: 2710587 [No Abstract] [Full Text] [Related]
2. [Clinical evaluation of drugs]. Wasielewski S Med Monatsschr Pharm; 1992 Feb; 15(2):34. PubMed ID: 1579074 [No Abstract] [Full Text] [Related]
3. Improving how we evaluate the toxicity of approved drugs. Reidenberg MM Clin Pharmacol Ther; 2006 Jul; 80(1):1-6. PubMed ID: 16815311 [No Abstract] [Full Text] [Related]
4. FDA signals it's open to drug trials that shift midcourse. Mathews AW Wall St J (East Ed); 2006 Jul; ():B1, B8. PubMed ID: 16858817 [No Abstract] [Full Text] [Related]
5. Prospects for reform of the IND/NDA processes: Part I. Romansky MA J Clin Psychopharmacol; 1982 Oct; 2(5):358-61. PubMed ID: 6752215 [No Abstract] [Full Text] [Related]
6. The Food and Drug Administration perspective: use of an investigational drug in a medical emergency. Schultheis LW; Rappaport BA Anesth Analg; 2007 Mar; 104(3):479-80. PubMed ID: 17312189 [No Abstract] [Full Text] [Related]
7. [Testing of drugs in humans. Current responsibilities and problems]. Weihrauch TR; Gunselmann W Fortschr Med; 1989 Feb; 107(5):124-8. PubMed ID: 2651250 [TBL] [Abstract][Full Text] [Related]
8. [Clinical drug testing in the United States]. Engelbart S Fortschr Med; 1983 Jun; 101(22):1021-2, 1049. PubMed ID: 6347848 [No Abstract] [Full Text] [Related]
9. Should it be easier or harder to use unapproved drugs and devices? Flannery EJ Hastings Cent Rep; 1986 Feb; 16(1):17-23. PubMed ID: 3514546 [TBL] [Abstract][Full Text] [Related]
10. Drug studies in children. Finkel MJ Pediatr Pharmacol (New York); 1980; 1(1):7-14. PubMed ID: 7346734 [No Abstract] [Full Text] [Related]
11. US drug trials said to ignore gender differences. Watson T Nature; 1992 Nov; 360(6399):6. PubMed ID: 1436074 [No Abstract] [Full Text] [Related]
12. Evidence used for approval of new drugs. Botstein P Isr J Med Sci; 1986; 22(3-4):197-200. PubMed ID: 3528042 [TBL] [Abstract][Full Text] [Related]
14. Drug regulation: quo vadis? Goyan JE JAMA; 1988 Nov; 260(20):3052-3. PubMed ID: 3184370 [No Abstract] [Full Text] [Related]
15. FDA seeks swifter approval of drugs for some life-threatening or debilitating diseases. Marwick C JAMA; 1988 Nov; 260(20):2976. PubMed ID: 3184360 [No Abstract] [Full Text] [Related]
16. Drug development process for a product with a primary pediatric indication. Allen AJ; Michelson D J Clin Psychiatry; 2002; 63 Suppl 12():44-9. PubMed ID: 12562061 [TBL] [Abstract][Full Text] [Related]